Search results
7 Deeply Discounted Stocks With 100%+ Upside Potential
InvestorPlace· 5 days agoMany top technology companies with the largest market capitalizations have made significant rebounds...
General Catalyst-backed Jasper Health lays off staff
TechCrunch· 7 days agoJasper Health, a cancer care platform startup, laid off a substantial part of its workforce, TechCrunch has learned. Engineering and product design were...
Blue-Chip Behemoths: 3 Industry Giants Trading at Shockingly Low Prices
InvestorPlace· 3 days agoThe stock market is near fresh new all-time highs. Valuations are reaching ever loftier peaks, and...
5 Must-Have Stocks In Today's Market
Benzinga via Yahoo Finance· 3 days agoEven as the presidential contest gets underway, the stock market keeps setting fresh all-time highs despite residual worries about inflation and...
Influencers Are Driving a New Category of Unionizing: Pharmacists
The Wall Street Journal· 3 days agoPharmacists have taken to social media, under handles like “The Accidental Pharmacist” and...
Need a pharmacy? These states and neighborhoods have less access
Providence Business News· 4 days agoOpening stores used to mean everything to pharmacy chains. CVS Health Corp. once boasted of opening...
Texas ties for second as the state with the most Fortune 500 companies: See list
Austin American-Statesman via Yahoo Finance· 3 days agoThis article originally appeared on Austin...
The share of Fortune 500 companies run by women CEOs stays flat at 10.4% as pace of change stalls
Fortune via Yahoo Finance· 3 days agoTownes-Whitley is a new CEO among this group; she took over from another female CEO, Nazzic Keene....
Pittsburgh loses 2 companies on the 2024 Fortune 500 list - Pittsburgh Business Times
The Business Journals· 3 days agoOn Tuesday, Fortune released its annual Fortune 500, a list of the biggest companies in the United...
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges...
Benzinga· 4 hours agoAbbVie Inc’s ABBV top-selling arthritis drug, Humira, has managed to retain over 80% of its patients even after facing nine lower-priced rivals in the U.S. over the past year, Reuters reports ...